Abstract:Objective: To construct the recombined phage which was inserted with the gene of extracellular domain of chicken EGFR as a new type vaccine and to evaluate the efficiency of the phage vaccine against the EGFR positive tumor. Methods: The T7 phage display system was used to display 5 fragments of the extracellular domain of chicken EGFR. The EGFR was expressed as a fused protein on the surface of the T7 phage 10B capsid protein. The EGFR expression of the phage vaccine was verified by the Western blot analysis. The anti-EGFR antibody was detected by ELISA. The splenic lymphocytes of the immunized mice were separated and used to determine the cellular immunotoxic effect against A431 cells. The phage vaccines were injected into the C57 mice 4 times before lewis lung cancer cells were inoculated. The tumor volume was recorded to evaluate the anti-tumor effect of each vaccine. Results: Five phage vaccines inserted with the chicken EGFR gene were constructed successfully. Western blot assay showed that the extracellular domain of chicken EGFR proteins was displayed on the surface of the phage. The specific antibody was induced in the immunized mice compared with the control group. The splenic lymphocytes of the immunized mice were shown to be immunotoxic against A431 cells. The killing rates of the experimental groups were higher than in the control group (P<0.001, by t test). The highest killing rate was (45.74±7.21)%. The tumor growth was inhibited in the experimental groups as compared with the control group (P<0.05 in C1, C2, C3 and C4 groups, P>0.05 in C5 group). Conclusion: The phage vaccine could induce both the protective and therapeutic antitumor immunity against EGFR-positive tumor.

Construction of Membrane-lytic Immunotoxin by Melittin and Epidermal Growth Factor

Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.

Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.

Expression,purification and Preliminary Identification of a Novel Immunotoxin Against Hepatocarcinoma

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM.

Construction and the Immune Reactivity of the Anti-cancer Vaccine of Recombinant Bacteriophage T7 Targeting Epidermical Growth Factor Receptor

[Immunotherapeutic Effect of Recombinant EGFR Phage Vaccine on Tumors].

Immunotherapy of EGFR-positive Tumor Based on Recombinant EGFR Phage Vaccine

Expression and Purification of Recombinant Atf-Mellitin, A New Type Fusion Protein Targeting Ovarian Cancer Cells, in P. Pastoris

Preparation and Functional Characterization of Human Vascular Endothelial Growth Factor-Melittin Fusion Protein with Analysis of the Antitumor Activity in Vitro and in Vivo.

Melittin-encapsulating Peptide Hydrogels for Enhanced Delivery of Impermeable Anticancer Peptides.

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL

Expression and Functional Characterization of a Recombinant Targeted Toxin with an Upa Cleavable Linker in Pichia Pastoris.

Genetically engineered epidermal growth factor conjugate crosses cell membrane

IgG-Engineered Protective Antigen for Cytosolic Delivery of Proteins into Cancer Cells

Selective Inhibition of Cancer Cells by Enzyme-Induced Gain of Function of Phosphorylated Melittin Analogues.

Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.

Melanocyte-Stimulating Hormone-Related Diphtheria Toxin Targets to Lung Adenocarcinoma

An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer